Hematologic dynamics during pregnancy and their association with obstetric complications: a retrospective cohort

Veronica Tozzo1,2,3, Rachel Petherbridge1,2, Kaitlyn James4

  • 1Department of Pathology and Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.

Insights

Elevated red blood cell counts during pregnancy, particularly significant increases, are linked to a higher risk of obstetric complications. These findings help establish new reference intervals for complete blood counts in pregnant individuals.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Reproductive Medicine

Background:

  • Pregnancy significantly alters hematologic parameters, necessitating updated reference intervals for complete blood counts (CBCs).
  • Existing reference intervals for CBCs in pregnancy may not accurately reflect longitudinal changes in diverse populations.

Purpose of the Study:

  • To establish gestational age-specific reference intervals for CBCs and their longitudinal changes in a large US cohort.
  • To investigate the association between extreme CBC values and changes with obstetric complications.

Main Methods:

  • Retrospective cohort study utilizing electronic health records from 1998-2022.
  • Inclusion of discovery and validation cohorts comprising over 96,000 singleton pregnancies.
  • Analysis of CBC indices and composite obstetric outcomes using generalized estimating equations.

Main Results:

  • Elevated hematocrit, hemoglobin, and red cell count values were associated with increased risk of composite obstetric complications.
  • Significant increases in hemoglobin and red cell count during pregnancy correlated with a higher risk of preterm birth.
  • Established reference intervals were often wider than previously published values for several CBC indices.

Conclusions:

  • Higher red blood cell counts and substantial intra-pregnancy increases in these measures are associated with adverse obstetric outcomes.
  • The study provides crucial data for refining diagnostic criteria and monitoring pregnant individuals.
Abstract

Related Concept Videos

Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.3K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.0K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.3K